Therapeutic Perspectives for Melatonin Agonists and Antagonists
P Delagrange(Institut de Relations Internationales et Stratégiques), Pierre‐Yves Renard(Centre National de la Recherche Scientifique), Jean A. Boutin(Inserm), Daniel Lesieur, Luc Pénicaud(Centre National de la Recherche Scientifique), Louis Casteilla(Centre National de la Recherche Scientifique), Jeffrey Atkinson(Laboratoire de Chimie Physique et Microbiologie pour l'Environnement), Sonia Pellissier(Université Savoie Mont Blanc), René Misslin(Centre National de la Recherche Scientifique)
Cited by 67
Related Papers
Crystal structures of human cholinesterases in complex with huprine W and tacrine: elements of specificity for anti-Alzheimer's drugs targeting acetyl- and butyryl-cholinesterase
|Biochemical Journal|2013|461
Reactivators of Acetylcholinesterase Inhibited by Organophosphorus Nerve Agents
|Accounts of Chemical Research|2012|399
Covalent Modification of Biomolecules through Maleimide-Based Labeling Strategies
|Bioconjugate Chemistry|2018|240
Novel naphthalenic ligands with high affinity for the melatonin receptor
|Journal of Medicinal Chemistry|1992|232
Water-Soluble BODIPY Derivatives
|Organic Letters|2009|188